The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007
Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcripti...
Ausführliche Beschreibung
Autor*in: |
Balez, Rachelle [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2020transfer abstract |
---|
Übergeordnetes Werk: |
Enthalten in: Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study - Hamood, Rola ELSEVIER, 2018, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:42 ; year:2020 ; pages:0 |
Links: |
---|
DOI / URN: |
10.1016/j.scr.2020.101701 |
---|
Katalog-ID: |
ELV049260944 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV049260944 | ||
003 | DE-627 | ||
005 | 20230626023853.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200518s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.scr.2020.101701 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000968.pica |
035 | |a (DE-627)ELV049260944 | ||
035 | |a (ELSEVIER)S1873-5061(20)30003-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.85 |2 bkl | ||
100 | 1 | |a Balez, Rachelle |e verfasserin |4 aut | |
245 | 1 | 4 | |a The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 |
264 | 1 | |c 2020transfer abstract | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. | ||
520 | |a Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. | ||
700 | 1 | |a Berg, Tracey |4 oth | |
700 | 1 | |a Bax, Monique |4 oth | |
700 | 1 | |a Muñoz, Sonia Sanz |4 oth | |
700 | 1 | |a Cabral-da-Silva, Mauricio C. |4 oth | |
700 | 1 | |a Engel, Martin |4 oth | |
700 | 1 | |a Do-Ha, Dzung |4 oth | |
700 | 1 | |a Stevens, Claire H. |4 oth | |
700 | 1 | |a Rowe, Dominic |4 oth | |
700 | 1 | |a Yang, Shu |4 oth | |
700 | 1 | |a Blair, Ian P. |4 oth | |
700 | 1 | |a Ooi, Lezanne |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Hamood, Rola ELSEVIER |t Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |d 2018 |g Amsterdam [u.a.] |w (DE-627)ELV001654470 |
773 | 1 | 8 | |g volume:42 |g year:2020 |g pages:0 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.scr.2020.101701 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.85 |j Kardiologie |j Angiologie |q VZ |
951 | |a AR | ||
952 | |d 42 |j 2020 |h 0 |
author_variant |
r b rb |
---|---|
matchkey_str |
balezrachellebergtraceybaxmoniquemuozson:2020----:hmnbsdergamnofbolssrmsde0gaiilmorpiltrlceoipteton |
hierarchy_sort_str |
2020transfer abstract |
bklnumber |
44.85 |
publishDate |
2020 |
allfields |
10.1016/j.scr.2020.101701 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000968.pica (DE-627)ELV049260944 (ELSEVIER)S1873-5061(20)30003-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Balez, Rachelle verfasserin aut The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 2020transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. Berg, Tracey oth Bax, Monique oth Muñoz, Sonia Sanz oth Cabral-da-Silva, Mauricio C. oth Engel, Martin oth Do-Ha, Dzung oth Stevens, Claire H. oth Rowe, Dominic oth Yang, Shu oth Blair, Ian P. oth Ooi, Lezanne oth Enthalten in Elsevier Hamood, Rola ELSEVIER Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study 2018 Amsterdam [u.a.] (DE-627)ELV001654470 volume:42 year:2020 pages:0 https://doi.org/10.1016/j.scr.2020.101701 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 42 2020 0 |
spelling |
10.1016/j.scr.2020.101701 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000968.pica (DE-627)ELV049260944 (ELSEVIER)S1873-5061(20)30003-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Balez, Rachelle verfasserin aut The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 2020transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. Berg, Tracey oth Bax, Monique oth Muñoz, Sonia Sanz oth Cabral-da-Silva, Mauricio C. oth Engel, Martin oth Do-Ha, Dzung oth Stevens, Claire H. oth Rowe, Dominic oth Yang, Shu oth Blair, Ian P. oth Ooi, Lezanne oth Enthalten in Elsevier Hamood, Rola ELSEVIER Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study 2018 Amsterdam [u.a.] (DE-627)ELV001654470 volume:42 year:2020 pages:0 https://doi.org/10.1016/j.scr.2020.101701 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 42 2020 0 |
allfields_unstemmed |
10.1016/j.scr.2020.101701 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000968.pica (DE-627)ELV049260944 (ELSEVIER)S1873-5061(20)30003-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Balez, Rachelle verfasserin aut The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 2020transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. Berg, Tracey oth Bax, Monique oth Muñoz, Sonia Sanz oth Cabral-da-Silva, Mauricio C. oth Engel, Martin oth Do-Ha, Dzung oth Stevens, Claire H. oth Rowe, Dominic oth Yang, Shu oth Blair, Ian P. oth Ooi, Lezanne oth Enthalten in Elsevier Hamood, Rola ELSEVIER Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study 2018 Amsterdam [u.a.] (DE-627)ELV001654470 volume:42 year:2020 pages:0 https://doi.org/10.1016/j.scr.2020.101701 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 42 2020 0 |
allfieldsGer |
10.1016/j.scr.2020.101701 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000968.pica (DE-627)ELV049260944 (ELSEVIER)S1873-5061(20)30003-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Balez, Rachelle verfasserin aut The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 2020transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. Berg, Tracey oth Bax, Monique oth Muñoz, Sonia Sanz oth Cabral-da-Silva, Mauricio C. oth Engel, Martin oth Do-Ha, Dzung oth Stevens, Claire H. oth Rowe, Dominic oth Yang, Shu oth Blair, Ian P. oth Ooi, Lezanne oth Enthalten in Elsevier Hamood, Rola ELSEVIER Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study 2018 Amsterdam [u.a.] (DE-627)ELV001654470 volume:42 year:2020 pages:0 https://doi.org/10.1016/j.scr.2020.101701 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 42 2020 0 |
allfieldsSound |
10.1016/j.scr.2020.101701 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000968.pica (DE-627)ELV049260944 (ELSEVIER)S1873-5061(20)30003-9 DE-627 ger DE-627 rakwb eng 610 VZ 44.85 bkl Balez, Rachelle verfasserin aut The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 2020transfer abstract nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. Berg, Tracey oth Bax, Monique oth Muñoz, Sonia Sanz oth Cabral-da-Silva, Mauricio C. oth Engel, Martin oth Do-Ha, Dzung oth Stevens, Claire H. oth Rowe, Dominic oth Yang, Shu oth Blair, Ian P. oth Ooi, Lezanne oth Enthalten in Elsevier Hamood, Rola ELSEVIER Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study 2018 Amsterdam [u.a.] (DE-627)ELV001654470 volume:42 year:2020 pages:0 https://doi.org/10.1016/j.scr.2020.101701 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 42 2020 0 |
language |
English |
source |
Enthalten in Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study Amsterdam [u.a.] volume:42 year:2020 pages:0 |
sourceStr |
Enthalten in Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study Amsterdam [u.a.] volume:42 year:2020 pages:0 |
format_phy_str_mv |
Article |
bklname |
Kardiologie Angiologie |
institution |
findex.gbv.de |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |
authorswithroles_txt_mv |
Balez, Rachelle @@aut@@ Berg, Tracey @@oth@@ Bax, Monique @@oth@@ Muñoz, Sonia Sanz @@oth@@ Cabral-da-Silva, Mauricio C. @@oth@@ Engel, Martin @@oth@@ Do-Ha, Dzung @@oth@@ Stevens, Claire H. @@oth@@ Rowe, Dominic @@oth@@ Yang, Shu @@oth@@ Blair, Ian P. @@oth@@ Ooi, Lezanne @@oth@@ |
publishDateDaySort_date |
2020-01-01T00:00:00Z |
hierarchy_top_id |
ELV001654470 |
dewey-sort |
3610 |
id |
ELV049260944 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049260944</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626023853.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.scr.2020.101701</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000968.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049260944</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1873-5061(20)30003-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Balez, Rachelle</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berg, Tracey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bax, Monique</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Muñoz, Sonia Sanz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cabral-da-Silva, Mauricio C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engel, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Do-Ha, Dzung</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stevens, Claire H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rowe, Dominic</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Shu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blair, Ian P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ooi, Lezanne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hamood, Rola ELSEVIER</subfield><subfield code="t">Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001654470</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:42</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.scr.2020.101701</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">42</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
author |
Balez, Rachelle |
spellingShingle |
Balez, Rachelle ddc 610 bkl 44.85 The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 |
authorStr |
Balez, Rachelle |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV001654470 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ 44.85 bkl The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 |
topic |
ddc 610 bkl 44.85 |
topic_unstemmed |
ddc 610 bkl 44.85 |
topic_browse |
ddc 610 bkl 44.85 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
t b tb m b mb s s m ss ssm m c c d mcc mccd m e me d d h ddh c h s ch chs d r dr s y sy i p b ip ipb l o lo |
hierarchy_parent_title |
Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |
hierarchy_parent_id |
ELV001654470 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV001654470 |
title |
The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 |
ctrlnum |
(DE-627)ELV049260944 (ELSEVIER)S1873-5061(20)30003-9 |
title_full |
The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 |
author_sort |
Balez, Rachelle |
journal |
Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |
journalStr |
Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2020 |
contenttype_str_mv |
zzz |
container_start_page |
0 |
author_browse |
Balez, Rachelle |
container_volume |
42 |
class |
610 VZ 44.85 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Balez, Rachelle |
doi_str_mv |
10.1016/j.scr.2020.101701 |
dewey-full |
610 |
title_sort |
mrna-based reprogramming of fibroblasts from a sod1 e101g familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line uowi007 |
title_auth |
The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 |
abstract |
Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. |
abstractGer |
Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. |
abstract_unstemmed |
Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007 |
url |
https://doi.org/10.1016/j.scr.2020.101701 |
remote_bool |
true |
author2 |
Berg, Tracey Bax, Monique Muñoz, Sonia Sanz Cabral-da-Silva, Mauricio C. Engel, Martin Do-Ha, Dzung Stevens, Claire H. Rowe, Dominic Yang, Shu Blair, Ian P. Ooi, Lezanne |
author2Str |
Berg, Tracey Bax, Monique Muñoz, Sonia Sanz Cabral-da-Silva, Mauricio C. Engel, Martin Do-Ha, Dzung Stevens, Claire H. Rowe, Dominic Yang, Shu Blair, Ian P. Ooi, Lezanne |
ppnlink |
ELV001654470 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.scr.2020.101701 |
up_date |
2024-07-06T21:04:48.590Z |
_version_ |
1803865175979196416 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049260944</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626023853.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.scr.2020.101701</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000968.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049260944</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1873-5061(20)30003-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Balez, Rachelle</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The mRNA-based reprogramming of fibroblasts from a SOD1 E101G familial amyotrophic lateral sclerosis patient to induced pluripotent stem cell line UOWi007</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020transfer abstract</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dermal fibroblasts were donated by a 43 year old male patient with clinically diagnosed familial amyotrophic lateral sclerosis (ALS), carrying the SOD1 E101G mutation. The induced pluripotent stem cell (iPSC) line UOWi007-A was generated using repeated mRNA transfections for pluripotency transcription factors Oct4, Klf4, Sox2, c-Myc, Lin28 and Nanog. The iPSCs carried the SOD1 E101G genotype and had a normal karyotype, expressed expected pluripotency markers and were capable of in vitro differentiation into endodermal, mesodermal and ectodermal lineages. This iPSC line may be useful for investigating familial ALS resulting from a SOD1 E101G mutation.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berg, Tracey</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bax, Monique</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Muñoz, Sonia Sanz</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cabral-da-Silva, Mauricio C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engel, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Do-Ha, Dzung</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stevens, Claire H.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rowe, Dominic</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Shu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blair, Ian P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ooi, Lezanne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hamood, Rola ELSEVIER</subfield><subfield code="t">Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV001654470</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:42</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.scr.2020.101701</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">42</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
score |
7.39983 |